GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » PB Ratio

Sinco Pharmaceutical Holdings (HKSE:06833) PB Ratio : 0.70 (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), Sinco Pharmaceutical Holdings's share price is HK$0.237. Sinco Pharmaceutical Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.34. Hence, Sinco Pharmaceutical Holdings's PB Ratio of today is 0.70.

Good Sign:

Sinco Pharmaceutical Holdings Ltd stock PB Ratio (=0.7) is close to 10-year low of 0.67

The historical rank and industry rank for Sinco Pharmaceutical Holdings's PB Ratio or its related term are showing as below:

HKSE:06833' s PB Ratio Range Over the Past 10 Years
Min: 0.66   Med: 2.94   Max: 31.25
Current: 0.7

During the past 10 years, Sinco Pharmaceutical Holdings's highest PB Ratio was 31.25. The lowest was 0.66. And the median was 2.94.

HKSE:06833's PB Ratio is ranked better than
81.52% of 92 companies
in the Medical Distribution industry
Industry Median: 1.425 vs HKSE:06833: 0.70

During the past 12 months, Sinco Pharmaceutical Holdings's average Book Value Per Share Growth Rate was 1.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 42.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 93.60% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Sinco Pharmaceutical Holdings was 148.30% per year. The lowest was -56.50% per year. And the median was 22.30% per year.

Back to Basics: PB Ratio


Sinco Pharmaceutical Holdings PB Ratio Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings PB Ratio Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.94 2.54 7.71 0.80 0.71

Sinco Pharmaceutical Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.71 4.16 0.80 0.89 0.71

Competitive Comparison of Sinco Pharmaceutical Holdings's PB Ratio

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's PB Ratio falls into.



Sinco Pharmaceutical Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sinco Pharmaceutical Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.237/0.338
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Sinco Pharmaceutical Holdings  (HKSE:06833) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Sinco Pharmaceutical Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines